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Abstract
The incidence of traumatic neuroma is extremely low, especially in those patients with breast cancer after
mastectomy. There are only 10 cases reported in the literature. We report a patient who developed a palpable
nodular mass near the mastectomy scar. The result of excisional biopsy was traumatic neuroma. Review of the
literature reveal 10 cases with breast cancer of traumatic neuromas after mastectomy. Traumatic neuroma is a
benign lesion and a reparative response of the nerve to injury, either direct/indirect trauma or chronic
inflammation. Benign lesions as traumatic neuromas are more rarely seen after mastectomy. However, in order to
manage patients’ treatment, the most critical problem is to distinguish it from recurrent breast carcinoma.
Although assistant examination methods such as ultrasound and computed tomography are valuable to a certain
extent, the final diagnosis can only be confirmed on pathologic examination.
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Background
Traumatic neuromas are uncommon benign lesions,
especially being the consequence of surgical procedures
[1,2]. A traumatic neuroma is not a true neoplasm. It
represents a hyperplastic, reparative response of the
nerve to injury and usually presents as a palpable nodule
mass. It is secondary to the disordered proliferation of
nerves and connective tissue trying to renervate the area
after a total or partial sectioning of anerve during an
accidental or surgical trauma [3]. Traumatic neuromas
occurring near the mastectomy scar are more rare. The
first reported case was in 2000 and there have been only
a total of 10 published cases [4-8]. Although post-mas-
tectomy traumatic neuromas are benign lesions, they
have to be distinguished from recurrent breast carcino-
mas to better manage patients’ next treatment.
We present herein a further case of post-mastectomy
traumatic neuroma and review the literature on the rare
condition.
Case report
A 43-year-old yellow female noticed a lump in the right
breast in 2007. Examination at that time revealed a
palpable mass without pain and the size of it was about
3 × 2 cm.
Ultrasonographic examination showed an irregular,
solid, hypoechoic mass in the right breast. The internal
echo texture was considered heterogeneous. There was
no abnormality in her left breast. This finding can per-
mit us to suspect that the mass is malignant. The next
day, the patient underwent right-sided modified radical
mastectomy (MRM). Histopathological examination
showed T2N0M0 invasive ductal carcinoma of the
breast. One week after the surgery, the patient started to
receive six cycles of taxol-based chemotherapy. In con-
sideration of her ER and PR status, the patient was trea-
ted with tamoxifen (TAM).
A nodular mass was detected at the chest wall 2 years
after the surgery. The nodular mass was close to the
mastectomy scar and was palpated at follow-up exami-
nation. Ultrasonographic examination showed a well-cir-
cumscribed, echo-heterogeneous, subcutaneous nodular
lesion, with a diameter of about 0.5 cm. (Figure 1)
There was no obvious indicator to identify the distant
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recurrence cancer or not, an excision biopsy was per-
formed of the presenting mass. Histopathological exami-
nation showed a tangle of small and medium nerve fiber
bundles which were well circumscribed in fibro-adipose
tissue. (Figure 2) Hence, we could confirm that the nod-
ular mass was traumatic neuroma and there was no
recurrence.
Discussion
A review of the literature searching for patients with
breast cancer and traumatic neuroma revealed a total of
10 reported cases [4-8]. This article presents an addi-
tional case with breast cancer of traumatic neuroma
occurring in a patient 2 years after mastectomy and
reviews the previously reported cases.
Table 1 summarizes the clinical circumstances for
the 10 reported cases plus this report of traumatic
neuroma after mastectomy for breast cancer. The age
of the patients at presentation was variable, ranging
from 41 to 68 years. The time between mastectomy
and presentation with traumatic neuroma was also
variable in these 11 cases (2 to 14 years after
mastectomy) and the average was 5.3 years. There was
only one patient who had three nodules near the mas-
tectomy scar and all other patients had only one
nodule. The diameter of every nodule ranged from 0.4
to 1.0 cm. There were 7 patients whose traumatic neu-
romas were located near the scar of mastectomy, 2
patients whose traumatic neuromas were located in the
subclavian area, one patient whose traumatic neuroma
was in the axilla and one patient whose traumatic neu-
roma was located in the 9 o’clock position in the right
chest wall. Eight patients underwent ultrasound exami-
nation. Reports showed five cases with well-circum-
scribed, homogeneous, hypo-echoic subcutaneous
nodular lesion and two cases with a poorly defined
hypo-echoic nodule with good conduction. The latest
r e p o r tf r o mK i mE Ye ta ls h o w e st h a ti tw a sa no v a l ,
circumscribed, hypo-echoic nodule with a partially
microlobulated margin [8]. Two cases in one report
didn’t mention whether they underwent ultrasound
examination or not. Ultrasound examination of the
case we present showed that the mass was a well-cir-
cumscribed, echo-heterogeneous, subcutaneous nodu-
lar lesion, with a diameter of about 0.5 cm.
Figure 1 Ultrasound examination shows a well-circumscribed, echo-heterogeneous, subcutaneous nodular lesion, with a max
diameter is0.5 cm.
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received excision biopsy of the presenting nodules and
made a definite diagnosis by histopathological
examination.
Table 2 summarizes the diagnosis and treatment of
breast cancer for reported cases. The age at diagnosis of
breast cancer was variable, ranging from 33 to 63 years.
Four patients’ stage was T1N0M0, five patients’ stage was
T2N0M0, and two patients’ stage was T2N1M0. Patholo-
gical examination of all the patients was invasive ductal
carcinoma of the breast. A majority of patients under-
went a radical or modified radical mastectomy (There
were two cases of a report did not mention the kind of
surgery). Seven patients received chemotherapy (specific
chemotherapy regimen and cycles are recorded in the
Table). Two patients received radiotherapy and five
patients received endocrinotherapy in consideration of
their ER and PR status (four patients treated with tamoxi-
fen and one patient treated with aromatase inhibitor).
Neuromas occurred in patients who have received can-
cer surgery are not well established in the literature,
unlike traumatic neuromas following amputation for
benign diseases such as post-cholecystectomy [2]. A trau-
matic neuroma is not a true neoplasm. It represents a
hyperplastic reponse of the nerve to injury, either direct/
indirect trauma or chronic inflammation. Traumatic neu-
romas show disrupted axons with distal demyelination
and Wallerian degeneration, and a tangled mass of
Schwannou cells and fibroblasts, all in a dense, collage-
nous matrix [3]. Enzinger FM et al [9] and Murphey M at
el [10] consider that a traumatic neuroma usually pre-
sents as a palpable nodule which is caused by a non-neo-
plastic proliferation of the proximal end of a severed,
partially transected or injoured nerve after surgery and it
dosen’t have any potential malignancy. Although most
traumatic neuromas affect peripheral sensory nerves,
they could also affect motor sensory nerves and auto-
nomic nervous system [11]. The most frequent site of
traumatic neuroma is at radically dissected neck, fol-
lowed by upper and lower extremities [12].
Benign lesions as traumatic neuromas after mastect-
omy are more rarely seen. The first reported case was in
2000 and there have been only a total of ten published
cases. Two of them resembled granular cell tumours at
mastectomy. Sometimes there was pain in tumor sites
but all of the post-mastectomy patients in the review
were asymptomatic. Hence, a traumatic neuroma after
mastectomy is an uncommon entity, but it should be
Figure 2 A tangle of small and medium nerve fibre bundles which were well circumscribed in fibro-adipose tissue.
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distinguish the painless nodule from recurrent breast
carcinoma. Assistant examination methods such as
ultrasound and computed tomography are valuable to a
certain extent. Kim EY et al [8] suggested that if a color
Doppler image shows no increased blood flow, fluoro-
deoxyglucose (FDG) positron emission tomography-
computed tomography (PET-CT) shows no significant
uptake, and the time interval between surgery and the
development of new lesion is more than 5 years, one
should include traumatic neuromas in the differential
diagnosis. Huang LF et al [13] and Yabuuchi H et al [2]
also suggested that several imaging techniques such as
ultrasonographic, computed tomographic, and magnetic
resonance imaging features have been used to differenti-
ate traumatic neuroma from recurrent lymphadenopthy
after neck dissection. Nevertheless, the final diagnosis
can only be confirmed on pathologic examination.
Conclusion
It is very difficult to diagnose traumatic neuromas
occurring in mastectomy scars because they can mimic
recurrent lymph nodes or local tumor recurrence. In
order to manage patients’ treatment, the most critical
problem is to distinguish it from recurrent breast carci-
noma. Although some assistant examination methods
are valuable to a certain extent, the final diagnosis can
only be confirmed on pathologic examination.
Table 1 Clinical datas for reported cases of traumatic neuroma after mastectomy for breast cancer
Source Age
(yr)
Period of neuroma
after mastectomy(yr)
The amount and
diameter of nodules
Location Ultrasound description Pain
Present
case
45 2 One;  = 0.5 Close to the mastectomy
scar
Well circumscribed, echo-heterogeneous,
subcutaneous nodular lesion
-
Xing
Wang et
al,
68 7.5 One;  = 0.7 cm Close to the mastectomy
scar
Well circumscribed, homogeneous, hypo-
echoic
-
2007[5] subcutaneous nodular lesion
Xing
Wang et
al,
45 2.83 Three; = 0.8 cm, 0.6
cm, 0.4 cm
Close to the mastectomy
scar
Three well defined, homogeneous, -
2007[5] hypo-echoic nodules
Xing
Wang et
al,
57 8 One;  = 0.7 cm Subclavicular Poorly defined hypo-echoic nodule with -
2007[5] good conduction
Xing
Wang et
al,
43 4 One;  = 1.0 cm Axilla Poorly defined hypo-echoic nodule with -
2007[5] good conduction
Xing
Wang et
al,
41 8 One;  = 1.0 cm Subclavicular Homogeneous, hypo-echoic subcutaneous -
2007[5] nodular lesion
Xing
Wang et
al,
52 3 One;  = 0.9 cm Close to the mastectomy
scar
Well defined, homogeneous, hypo-echoic -
2007[5] subcutaneous nodular lesion
Rosso R
et al,
55 2.33 One;  = 0.4 cm Close to the mastectomy
scar
Not mentioned -
2000[4]
Rosso R
et al,
67 4.17 One;  = 0.6 cm Close to the mastectomy
scar
Not mentioned -
2000[4]
B
Baltalarli
et al
54 2 One;  = 1.0 cm On the mastectomy scar Well circumscribed, homogeneous, hypo- -
2004[7]
Kim EY
et al,
2011[8]
47 14 One;  = 1.0 cm In the 9 o’clock position in
the right chest wall
echoic subcutaneous nodular lesions
Oval, circumscribed, hypo-echoic nodule
with a partially microlobulated margin
-
 = diameter -: Negative
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Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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Table 2 The diagnosis and treatment of breast cancer for reported cases
Source Age at
diagnosis
(yr)
Tumor
size (cm)
Stage Kind of
surgery
Lymph nodes
metastasis
Chemotherapy Radiotherapy Endocrinotherapy ER PR
Present 43 3 × 2 T2N0M0 MRM 0/11 TEC, 6 cycles - TAM + +
case
Xing
Wang et
al,
61 2 × 2 T1N0M0 RM 0/19 CU, 4 cycles - TAM + +
2007[5]
Xing
Wang et
al,
42 3.5 × 3.5 T2N0M0 MRM 0/24 CMF, 6 cycles Only internal - - +
2007[5] Mammary
area
Xing
Wang et
al,
49 4 × 4 T2N1M0 MRM 4/20 CEF, 6 cycles - TAM + -
2007[5]
Xing
Wang et
al,
39 2.5 × 2.5 T2N0M0 MRM 0/18 CEF, 4 cycles - TAM + +
2007[5]
Xing
Wang et
al,
33 1.5 × 1.5 T1N0M0 MRM 0/15 - - - - -
2007[5]
Xing
Wang et
al,
49 5 × 4 T2N1M0 MRM 3/10 CEF, 6 cycles - TAM - +
2007[5]
Rosso R et
al,
53 / T1N0M0 MRM / - - / / /
2000[4]
Rosso R et
al,
63 / T1N0M0 / / - - / / /
2000[4]
B Baltalarli
et al,
52 / T2N0M0 / / Anthracycline-based External AI / /
2004[7]
Kim EY et
al,
2011[8]
33 / T2N0M0 MRM / chemotherapy, 4
cycles
Adjuvant
chemotherapy for 1
year*
Radiotherapy
-
// /
/: Not mentioned in the report +: Positive -: Negative or without treatment RM: Radical mastectomy. MRM: Modified Radical Mastectomy TEC: Taxol/Epirubicin/
Cyclophosphamide CMF: Cyclophosphamide/Methotrexate/Fluorouracil CU: Colchicines/Uraphetine CEF: Cyclophosphamide/Epirubicin/Flurouracil TAM: Tamoxifen
treatment AI: Aromatase inhibitor treatment *: No mention of specific d
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